rs587781619
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000455.5(STK11):c.465-3C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000125 in 1,599,262 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000455.5 splice_region, intron
Scores
Clinical Significance
Conservation
Publications
- familial pancreatic carcinomaInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Peutz-Jeghers syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, Genomics England PanelApp, G2P
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STK11 | NM_000455.5 | c.465-3C>T | splice_region_variant, intron_variant | Intron 3 of 9 | ENST00000326873.12 | NP_000446.1 | ||
STK11 | NM_001407255.1 | c.465-3C>T | splice_region_variant, intron_variant | Intron 3 of 8 | NP_001394184.1 | |||
STK11 | NR_176325.1 | n.1732-3C>T | splice_region_variant, intron_variant | Intron 4 of 10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STK11 | ENST00000326873.12 | c.465-3C>T | splice_region_variant, intron_variant | Intron 3 of 9 | 1 | NM_000455.5 | ENSP00000324856.6 | |||
STK11 | ENST00000652231.1 | c.465-3C>T | splice_region_variant, intron_variant | Intron 3 of 8 | ENSP00000498804.1 | |||||
STK11 | ENST00000585748.3 | c.93-3C>T | splice_region_variant, intron_variant | Intron 5 of 11 | 3 | ENSP00000477641.2 | ||||
STK11 | ENST00000593219.6 | n.*290-3C>T | splice_region_variant, intron_variant | Intron 4 of 10 | 3 | ENSP00000466610.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152238Hom.: 0 Cov.: 33 show subpopulations
GnomAD4 exome AF: 6.91e-7 AC: 1AN: 1447024Hom.: 0 Cov.: 32 AF XY: 0.00000139 AC XY: 1AN XY: 718464 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152238Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74366 show subpopulations
ClinVar
Submissions by phenotype
Peutz-Jeghers syndrome Uncertain:4
- -
ACMG classification criteria: PM2 moderated -
- -
This variant is not present in population databases (gnomAD no frequency). This sequence change falls in intron 3 of the STK11 gene. It does not directly change the encoded amino acid sequence of the STK11 protein. It affects a nucleotide within the consensus splice site. This variant has not been reported in the literature in individuals affected with STK11-related conditions. ClinVar contains an entry for this variant (Variation ID: 141268). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome Uncertain:1
The c.465-3C>T intronic variant results from a C to T substitution 3 nucleotides upstream from coding exon 4 in the STK11 gene. This variant was detected once in a cohort of 1663 Brazilian breast cancer patients who underwent hereditary multigene panel testing (Guindalini RSC et al. Sci Rep, 2022 Mar;12:4190). This nucleotide position is well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will not have any significant effect on splicing}; however, direct evidence is insufficient at this time (Ambry internal data). Based on the available evidence, the clinical significance of this variant remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at